Type: Prevalence/cross-sectional
Study Status: Completed
Enrollment Status: Closed
Countries: Kenya; Uganda; Rwanda; Zambia
Partners: Kenya AIDS Vaccine Initiative-Kangemi (KAVI-Kangemi), Nairobi, Kenya; Kenya AIDS Vaccine Initiative-Kenyatta National Hospital (KAVI-KNH), Nairobi, Kenya; Kenya Medical Research Institute-Centre for Geographic Medicine Research-Coast (KEMRI-CGMRC), Kilifi, Kenya; Uganda Virus Research Institute-International AIDS Vaccine Initiative (UVRI-IAVI)- Entebbe, Uganda; Medical Research Council (MRC-Masaka)-Masaka, Uganda; Projet San Francisco (PSF-Kigali)-Kigali, Rwanda; Zambia-Emory Research Project (ZEHRP)-Lusaka, Zambia.

Study Summary:
To establish clinical laboratory reference ranges among adults to determine relevant inclusion and exclusion criteria and to interpret safety data for HIV vaccine trials in the context of medical conditions present in an asymptomatic adult population at multiple sites in Africa.